Beta
Company data is growing.
← All companies
/
Top lists
/
Biogen
Biogen
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
11 449
12 274
13 453
14 378
13 445
10 982
10 173
9 836
9 676
9 891
Operating profit (EBIT)
5 150
5 344
5 889
7 043
4 550
2 841
—
—
—
—
Net income attributable to shareholders
3 703
2 539
4 431
5 889
4 001
1 556
3 047
1 161
1 632
1 293
EBIT margin
45,0%
43,5%
43,8%
49,0%
33,8%
25,9%
—
—
—
—
Gross margin
87,1%
86,7%
86,5%
86,4%
86,6%
80,8%
77,6%
74,2%
76,1%
75,7%
Operating cash flow
4 522
4 551
6 188
7 079
4 230
3 640
1 384
1 547
2 876
2 205
Free cash flow
3 906
4 548
6 130
6 564
3 805
3 382
1 381
1 513
2 669
2 051
Cash
2 327
1 574
1 225
2 914
—
—
—
—
—
—
Interest-bearing debt
6 517
5 938
5 937
5 955
15 638
7 273
14 493
7 088
8 044
14 499
0
5 000
10 000
15 000
0,0%
20,0%
40,0%
60,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
11 449
12 274
13 453
14 378
13 445
10 982
10 173
9 836
9 676
9 891
5 150
5 344
5 889
7 043
4 550
2 841